Expert guidance across pharma, biotech, and medical devices — stay ahead of industry trends and best practices.
Utilities such as pharmaceutical water systems and gases are often overlooked in Annex 1 remediation. Discover common compliance gaps and how to mitigate them.
Read article
Extractables and leachables requirements are evolving with draft ICH Q3E. Learn how companies can prepare for future E&L regulatory expectations.
Read more
Expanding across Europe introduces complex pharmacovigilance requirements. Learn how EU PV systems can scale while integrating national roles and regulatory obligations.
Read more
AI is transforming pharmacovigilance processes from case processing and literature monitoring to signal detection. Discover how AI and NLP can enhance efficiency, compliance, and regulatory intelligence.
Read more
Successful MedTech companies treat product development as a lifecycle strategy. Learn why regulatory planning, IP strategy and development must evolve together.
Read more
Developing Software as a Medical Device under EU MDR requires clear intended use, risk classification under Rule 11, and compliance with IEC 62304. Learn what SaMD developers need to know.
Read more
IP strategy should start early in MedTech development. Discover how patent strategy, regulatory classification, and product development influence IP protection for emerging MedTech companies.
Read more
EU MDR compliance can be challenging for emerging MedTech companies. Learn what MDR actually requires, from qualification and QMS to technical documentation and post-market obligations.
Read more
Many MedTech startups treat IP and regulatory strategy as separate disciplines. Discover the three most common mistakes and how aligning both early strengthens market access and product value.
Read more
Scientific Advice is one of the few moments in early development where a biotech can test its assumptions with regulators. Learn how to structure questions, integrate CMC and clinical strategy, and leverage EMA SME support for maximum impact.
Read more
Annex 1 places strong emphasis on personnel behaviour in sterile manufacturing. Learn how gowning, training, and aseptic discipline influence contamination control.
Read more
For US biotechs expanding into the EU and UK, successful submission conversion requires early planning, clear ownership, and a structured approach. Learn how to build a reuse map, manage parallel conversion tracks, and avoid late-stage rework.
Read more
The Annex 15 revision will make qualification and validation mandatory for API manufacturers. Learn how to prepare lifecycle validation and inspection readiness.
Read more